← All organizations
Acquired by Bristol-Myers Squibb on Jan 1, 1989
Timeline
1850s
- Jan 1, 1858
Squibb— Founded
- Jun 1, 1858
chloroform— Marketing Organization
1970s
- Aug 6, 1971
haloprogin— NDA Organization
1980s
- Jun 3, 1980
erythromycin— NDA Secondary Org
- Jan 1, 1989
Bristol-Myers Squibb— Acquired By
Indications
Approved for
- Abortion, Spontaneous
- Anemia, Sickle Cell
- Angina Pectoris
- Aspergillosis
- Bacterial Infections
- Blastomycosis
- Brain Neoplasms
- Candidiasis
- Candidiasis, Cutaneous
- Coccidioidomycosis
- Cryptococcosis
- Dermatitis, Seborrheic
- Diabetic Nephropathies
- Diabetic Retinopathy
- Heart Failure
- Histoplasmosis
- Hodgkin Disease
- Hypersensitivity
- Hypertension
- Hypertrichosis
- Infections
- Infertility, Female
- Intraabdominal Infections
- Leishmaniasis, Visceral
- Melanoma
- Meningitis, Cryptococcal
- Mucormycosis
- Mycoses
- Myocardial Infarction
- Obstetric Labor, Premature
- Otitis Media
- Pain
- Pneumonia
- Pruritus
- Pyelonephritis
- Respiratory Tract Infections
- Scabies
- Sepsis
- Skin Diseases, Bacterial
- Sporotrichosis
- Tachycardia, Ventricular
- Tinea
- Tinea Pedis
- Tinea Versicolor
- Urinary Tract Infections
- Vaginal Diseases
- Ventricular Dysfunction, Left
- Zygomycosis
Marketed drugs (20)
Details
- Founded
- Brooklyn, NY, US Jan 1, 1858
- First NDA
- Jul 1, 1953
- Last known activity
- Jul 23, 1987
Designations held
- Priority review